The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Open accessAbstract
The antidepressant action of cannabis as well as the interaction between antidepressants and the endocannabinoid system has been reported. This study was conducted to assess the antidepressant-like activity of Δ9-THC and other cannabinoids. Cannabinoids were initially evaluated in the mouse tetrad assay to determine doses that do not induce hypothermia or catalepsy. The automated mouse forced swim (FST) and tail suspension (TST) tests were used to determine antidepressant action. At doses lacking hypothermic and cataleptic effects (1.25, 2.5, and 5 mg/kg, i.p.), both Δ9-THC and Δ8-THC showed a U-shaped dose response with only Δ9-THC showing significant antidepressant-like effects at 2.5 mg/kg (p < 0.05) in the FST. The cannabinoids cannabigerol (CBG) and cannabinol (CBN) did not produce antidepressant-like actions up to 80 mg/kg in the mouse FST, while cannabichromene (CBC) and cannabidiol (CBD) exhibited significant effect at 20 and 200 mg/kg, respectively (p < 0.01). The antidepressant-like action of Δ9-THC and CBC was further confirmed in the TST. Δ9 -THC exhibited the same U-shaped dose response with significant antidepressant-like action at 2.5 mg/kg (p < 0.05) while CBC resulted in a significant dose dependent decrease in immobility at 40 and 80 mg/kg doses (p < 0.01). Results of this study show that Δ9-THC and other cannabinoids exert antidepressant-like actions, and thus may contribute to the overall mood-elevating properties of cannabis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,511
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 2×
“The endocannabinoid system is regarded as a neuromodulator, and is comprised of cannabinoid receptors (primarily CB1 and CB2 receptors), their endogenous ligands, and enzymes responsible for the synthesis and metabolism of these ligands (Devane et al., 1992; Dinh et al., 2002; Gong et al., 2006; Matsuda et al., 1990;…”
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094
Self-citationAgonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Cannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
Gobbi, G., Bambico, F. R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 673
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
Self-citationJiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461
Cannabis Abuse as a Risk Factor for Depressive Symptoms
Bovasso, G. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2033 · Cited by 452
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
Pertwee, R. G. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.025 · Cited by 444
Experimental Approaches to Anxiety and Depression
Elliott, J. M., Heal, D. J., & Mardens, C. A. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199310000-00012 · Cited by 361
Mombereau, C., Kaupmann, K., Froestl, W., Sansig, G., van der Putten, H., & Cryan, J. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300413 · Cited by 350
Cryan, J. F., Page, M. E., & Lucki, I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0093-5 · Cited by 321
Sim, L. J., Hampson, R. E., Deadwyler, S. A., & Childers, S. R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08057.1996 · Cited by 312
Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 311
Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
Hill, M., Miller, G., Ho, W.-S., Gorzalka, B., & Hillard, C. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-993211 · Cited by 292
Tzavara, E. T., Davis, R. J., Perry, K. W., Li, X., Salhoff, C., Bymaster, F. P., Witkin, J. M., & Nomikos, G. G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705100 · Cited by 269
Biphasic Effects of Anandamide
Sulcova, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00422-x · Cited by 257
Griebel, G., Stemmelin, J., & Scatton, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.032 · Cited by 253
Hill, M. N., & Gorzalka, B. B. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.03.003 · Cited by 231
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213 · cited 1×
“The complex picture of cannabinoid-induced response in this study and its function of the dose administered highly mimics the various emotional responses in humans following cannabis use, with users reporting both mood elevation as well as depressive symptoms (Leweke and Koethe, 2008).”
Withdrawal from chronic amphetamine induces Depressive-Like behavioral effects in rodents
Cryan, J. F., Hoyer, D., & Markou, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01730-4 · Cited by 199
Koethe, D., Llenos, I. C., Dulay, J. R., Hoyer, C., Torrey, E. F., Leweke, F. M., & Weis, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0660-5 · Cited by 187
Shearman, L. P., Rosko, K. M., Fleischer, R., Wang, J., Xu, S., Tong, X. S., & Rocha, B. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00001 · Cited by 186
Experimental approaches to anxiety and depression
McCall, W. V. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90335-v · Cited by 186
Biologically Active Cannabinoids from High-Potency Cannabis sativa
Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Khan, I. A., & Ross, S. A. (2009) · Journal of Natural Products · doi:10.1021/np900067k · Cited by 185 · cited 1×
“To date a total of 525 natural constituents covering several chemical classes have been isolated and identified from C. sativa (Ahmed et al., 2008a, 2008b; ElSohly and Slade, 2005; Radwan et al., 2008a, 2008b, 2009; Ross and ElSohly, 1995, Turner et al., 1980).”
Self-citationEvaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
Naidu, P. S., Varvel, S. A., Ahn, K., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0689-4 · Cited by 184 · cited 1×
“However, such data are in contrast with the study reported by Naidu et al. (2007) whereby URB597 administration failed to demonstrate antidepressant-like action in either the FST or TST.”
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 168
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test
Crowley, J. J., Blendy, J. A., & Lucki, I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0166-5 · Cited by 165
Renard, C. E., Dailly, É., David, D. J. P., Hascoët, M., & Bourin, M. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00160.x · Cited by 150
Non-cannabinoid constituents from a high potency Cannabis sativa variety
Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Wilson, L., El‐Alfy, A. T., Khan, I. A., & Ross, S. A. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.07.010 · Cited by 146
Self-citationThe tail suspension test: Ethical considerations
Thierry, B., St�ru, L., Simon, P., & Porsolt, R. D. (1986) · Psychopharmacology · doi:10.1007/bf00181261 · Cited by 141
Current perspectives on the development of non-biogenic amine-based antidepressants
Skolnick, P., Legutko, B., Li, X., & Bymaster, F. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0806 · Cited by 140
Liu, X., & Gershenfeld, H. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01028-3 · Cited by 136
Interactions between THC and cannabidiol in mouse models of cannabinoid activity
Varvel, S. A., Wiley, J. L., Yang, R., Bridgen, D. T., Long, K., Lichtman, A. H., & Martin, B. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0356-9 · Cited by 135
Varvel, S., Bridgen, D., Tao, Q., Thomas, B., Martin, B., & Lichtman, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080739 · Cited by 135
Bourin, M., Chenu, F., Ripoll, N., & David, D. J. P. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.06.015 · Cited by 128
Cannabinoid Ester Constituents from High-PotencyCannabis sativa
Ahmed, S. A., Ross, S. A., Slade, D., Radwan, M. M., Zulfiqar, F., & ElSohly, M. A. (2008) · Journal of Natural Products · doi:10.1021/np070454a · Cited by 125
Self-citationGrinspoon, L., & Bakalar, J. B. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399687 · Cited by 120
Isolation and Characterization of New Cannabis Constituents from a High Potency Variety
Radwan, M. M., Ross, S. A., Slade, D., Ahmed, S. A., Zulfiqar, F., & ElSohly, M. A. (2008) · Planta Medica · doi:10.1055/s-2008-1034311 · Cited by 115
Self-citationDoes Cannabis Use Affect Treatment Outcome in Bipolar Disorder?
van Rossum, I., Boomsma, M. M., Tenback, D. E., Reed, C. C., & van Os, J. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31819292a6 · Cited by 111
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
Witkin, J. M., Tzavara, E. T., Davis, R. J., Li, X., & Nomikos, G. G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.006 · Cited by 110
Automated tests for measuring the effects of antidepressants in mice
Crowley, J. J., Jones, M. D., O’Leary, O. F., & Lucki, I. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.014 · Cited by 109
Pertwee, R. G., Thomas, A., Stevenson, L. A., Ross, R. A., Varvel, S. A., Lichtman, A. H., Martin, B. R., & Razdan, R. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707124 · Cited by 105
Do patients use marijuana as an antidepressant?
Gruber, A. J., Pope, H. G., & Brown, M. E. (1996) · Depression · doi:10.1002/(sici)1522-7162(1996)4:2<77::aid-depr7>3.0.co;2-c · Cited by 104
Tzavara, E. T., Perry, K. W., Rodriguez, D. E., Bymaster, F. P., & Nomikos, G. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01228-6 · Cited by 71
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception
Booker, L., Naidu, P. S., Razdan, R. K., Mahadevan, A., & Lichtman, A. H. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.009 · Cited by 62
Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
Burkey, T. H., Quock, R. M., Consroe, P. F., Roeske, W. R., & Yamamura, H. I. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00146-5 · Cited by 61
CONSTITUENTS OF CANNABIS SATIVA L. XXVIII A REVIEW OF THE NATURAL CONSTITUENTS: 1980-1994
Ross, S., & EISohly, M. (1995) · Zagazig Journal of Pharmaceutical Sciences · doi:10.21608/zjps.1995.169714 · Cited by 59
Self-citationAhmed, S. A., Ross, S. A., Slade, D., Radwan, M. M., Khan, I. A., & ElSohly, M. A. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.07.178 · Cited by 54
Self-citationRutkowska, M., & Jachimczuk, O. (2004) · PubMed · Cited by 49
Lee, K. S., CLOUGH, A. R., Jaragba, M. J., Conigrave, K. M., & Patton, G. C. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01803.x · Cited by 47
Neuroanatomic Comparison of Bipolar Adolescents With and Without Cannabis Use Disorders
Jarvis, K., DelBello, M. P., Mills, N. P., Elman, I., Strakowski, S. M., & Adler, C. M. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.033 · Cited by 41
Non-cannabinoid constituents from a high potency Cannabis sativa variety
Radwan, M., ElSohly, M., Slade, D., Ahmed, S., Wilson, L., El-Alfy, A., & Ross, S. A. (2008) · Planta Medica · doi:10.1055/s-0028-1084474 · Cited by 10
Self-citation
Cited by
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312
Metadata
- Authors
- El-Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S., Radwan, M., Slade, D., Khan, I., ElSohly, M., & Ross, S.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 95
- Issue
- 4
- Pages
- 434-442
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2030021261
- Cited by
- 268
- References
- 70
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.